• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在大型早期宫颈癌中,功能性肿瘤浸润性 TH1 和 TH2 效应物被调节性 T 细胞抑制。

Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells.

机构信息

Department of Microbiology, Kidwai Memorial Institute of Oncology, Bangalore, India.

出版信息

Int J Gynecol Cancer. 2012 Sep;22(7):1130-7. doi: 10.1097/IGC.0b013e318262aa53.

DOI:10.1097/IGC.0b013e318262aa53
PMID:22872166
Abstract

OBJECTIVE

Analysis of tumor-infiltrating lymphocytes (TILs) is one of the cornerstones for the understanding of immune responses prevailing in the tumor microenvironment. We studied TILs from squamous cell carcinoma of the cervix ex vivo without proliferating them in vitro before analysis.

METHODS

Whereas TILs were magnetic activated cell separation enriched and flow sorted into CD4 CD25 (regulatory T cells [Tregs]), CD4 CD25 (effector T cells [Teffs]) were directly purified by flow cytometry, and both these subsets were characterized phenotypically and functionally. Tissue sections were probed for interleukin 4 (IL-4) and interferon γ.

RESULTS

Effector T cells constitutively expressed both interferon γ and IL-4 prototypical cytokines of TH1 and TH2, respectively, and were able to proliferate and secrete higher quantities of both cytokines in response to anti-CD3/anti-CD28 and autologous tumor lysates. Only 53% of cervical cancer Tregs were FOXP3, elaborated transforming growth factor β1, and IL-10 and were able to inhibit both T helper subsets.

CONCLUSIONS

Intratumoral Teffs represented functionally active subsets of both TH1 and TH2 that were not anergic but were suppressed by multiple Treg subsets, which comprised FOXP3 + Tregs and Tregs secreting transforming growth factor β1 and IL-10. These results imply that the microenvironment of cervical carcinomas harbored both TH1 and TH2 subsets of CD4 Teffs that were functionally active but were perhaps unable to perform because of the overpowering effect of Tregs.

摘要

目的

肿瘤浸润淋巴细胞(TILs)的分析是了解肿瘤微环境中免疫反应的基石之一。我们在体外未增殖的情况下,从宫颈鳞状细胞癌中离体研究了 TILs。

方法

通过磁激活细胞分离法富集 TILs,并通过流式细胞术直接对 CD4 CD25(调节性 T 细胞[Tregs])和 CD4 CD25(效应 T 细胞[Teffs])进行分离和纯化,然后对这两个亚群进行表型和功能特征分析。组织切片被用来探测白细胞介素 4(IL-4)和干扰素 γ。

结果

效应 T 细胞持续表达干扰素 γ和白细胞介素 4,分别为 TH1 和 TH2 的典型细胞因子,并且能够在抗 CD3/抗 CD28 和自体肿瘤裂解物的刺激下增殖并分泌更多数量的这两种细胞因子。只有 53%的宫颈癌 Tregs 表达 FOXP3,分泌转化生长因子 β1 和白细胞介素 10,并能够抑制两种辅助性 T 细胞亚群。

结论

肿瘤内 Teffs 代表了 TH1 和 TH2 的功能活跃亚群,它们不是无反应性的,但被多种 Treg 亚群抑制,这些 Treg 亚群包括 FOXP3+Tregs 和分泌转化生长因子 β1 和白细胞介素 10 的 Tregs。这些结果表明,宫颈癌的微环境中存在功能活跃的 CD4 Teffs 的 TH1 和 TH2 亚群,但由于 Tregs 的压倒性作用,它们可能无法发挥作用。

相似文献

1
Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells.在大型早期宫颈癌中,功能性肿瘤浸润性 TH1 和 TH2 效应物被调节性 T 细胞抑制。
Int J Gynecol Cancer. 2012 Sep;22(7):1130-7. doi: 10.1097/IGC.0b013e318262aa53.
2
Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.与子宫颈癌患者肿瘤引流淋巴结及外周血中的淋巴细胞相比,肿瘤浸润淋巴细胞含有更多数量的1型细胞因子表达细胞和DR+T细胞。
Gynecol Oncol. 2001 Jun;81(3):424-32. doi: 10.1006/gyno.2001.6200.
3
CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.经白细胞介素-2(IL-2)或白细胞介素-4(IL-4)体外同种异体激活的CD4+CD25+ T细胞成为具有不同表型的强效同种异体抗原特异性排斥抑制剂,提示由Th1和Th2反应介导的不同激活途径。
Blood. 2009 Jan 8;113(2):479-87. doi: 10.1182/blood-2008-05-156612. Epub 2008 Sep 30.
4
A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.分泌白细胞介素-10和转化生长因子-β1的CD4+CD25高表达Foxp3+ T细胞的一个独特亚群介导肿瘤微环境中的抑制作用。
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54. doi: 10.1158/1078-0432.CCR-07-0472.
5
CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.常见变异型免疫缺陷患儿的CD4+CD25+Foxp3+调节性T细胞、Th1(CCR5、IL-2、IFN-γ)和Th2(CCR4、IL-4、Il-13)型趋化因子受体及细胞内细胞因子
Int J Immunopathol Pharmacol. 2016 Jun;29(2):241-51. doi: 10.1177/0394632015617064. Epub 2015 Dec 18.
6
Regulatory T Cells Suppress Natural Killer Cell Immunity in Patients With Human Cervical Carcinoma.调节性T细胞抑制人宫颈癌患者的自然杀伤细胞免疫。
Int J Gynecol Cancer. 2016 Jan;26(1):156-62. doi: 10.1097/IGC.0000000000000578.
7
The disease stage-associated imbalance of Th1/Th2 and Th17/Treg in uterine cervical cancer patients and their recovery with the reduction of tumor burden.疾病阶段相关的宫颈癌患者 Th1/Th2 和 Th17/Treg 失衡及其随肿瘤负荷减少的恢复。
BMC Womens Health. 2020 Jun 17;20(1):126. doi: 10.1186/s12905-020-00972-0.
8
B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.B7-H4过表达会损害人宫颈癌中T细胞的免疫反应。
Hum Immunol. 2014 Dec;75(12):1203-9. doi: 10.1016/j.humimm.2014.10.002. Epub 2014 Oct 13.
9
Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌患者中调节性T细胞与CD8+效应细胞群体之间的关系。
Head Neck. 2007 Feb;29(2):120-7. doi: 10.1002/hed.20490.
10
CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice.CD4+CD25+Foxp3+ 调节性 T 细胞耗竭可能会减轻二氧化硅诱导的小鼠肺纤维化的发展。
PLoS One. 2010 Nov 3;5(11):e15404. doi: 10.1371/journal.pone.0015404.

引用本文的文献

1
Effects of dexmedetomidine and ketorolac applied for patient‑controlled analgesia on the balance of Th1/Th2 and level of VEGF in patients undergoing laparoscopic surgery for cervical cancer: A randomized controlled trial.右美托咪定与酮咯酸用于宫颈癌腹腔镜手术患者自控镇痛对Th1/Th2平衡及VEGF水平的影响:一项随机对照试验
Oncol Lett. 2024 Jun 17;28(2):379. doi: 10.3892/ol.2024.14512. eCollection 2024 Aug.
2
Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective.临床过继性调节性T细胞疗法:现状、挑战与展望。
Front Cell Dev Biol. 2023 Jan 30;10:1081644. doi: 10.3389/fcell.2022.1081644. eCollection 2022.
3
Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer.
宫颈癌过继性肿瘤浸润淋巴细胞细胞治疗。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2060019. doi: 10.1080/21645515.2022.2060019. Epub 2022 Apr 25.
4
Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets.宫颈癌的炎症谱:嘌呤能信号转导的影响及可能的治疗靶点。
Inflamm Res. 2022 Jun;71(5-6):555-564. doi: 10.1007/s00011-022-01560-8. Epub 2022 Apr 4.
5
Identifying Molecular Changes in Early Cervical Cancer Samples of Patients That Developed Metastasis.识别发生转移的患者早期宫颈癌样本中的分子变化。
Front Oncol. 2022 Jan 11;11:715077. doi: 10.3389/fonc.2021.715077. eCollection 2021.
6
Prognostic and therapeutic TILs of cervical cancer-Current advances and future perspectives.宫颈癌的预后和治疗性肿瘤浸润淋巴细胞——当前进展与未来展望
Mol Ther Oncolytics. 2021 Jul 21;22:410-430. doi: 10.1016/j.omto.2021.07.006. eCollection 2021 Sep 24.
7
The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.人乳头瘤病毒诱导的宫颈病变中的免疫微环境——雌激素作为免疫调节剂的证据。
Front Cell Infect Microbiol. 2021 Apr 30;11:649815. doi: 10.3389/fcimb.2021.649815. eCollection 2021.
8
Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer.全面的基因组和免疫表型分析浸润人三阴性乳腺癌的 CD4 T 细胞。
Cancer Immunol Immunother. 2021 Jun;70(6):1649-1665. doi: 10.1007/s00262-020-02807-1. Epub 2020 Dec 10.
9
Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma.经动脉化疗栓塞术对肝癌患者调节性 T 细胞及其亚群的影响。
Hepatol Int. 2020 Mar;14(2):249-258. doi: 10.1007/s12072-020-10014-4. Epub 2020 Feb 18.
10
The Formation and Therapeutic Update of Tumor-Associated Macrophages in Cervical Cancer.肿瘤相关巨噬细胞在宫颈癌中的形成与治疗进展。
Int J Mol Sci. 2019 Jul 5;20(13):3310. doi: 10.3390/ijms20133310.